A tetrazolium-based colorimetric assay for metabolic activity of stored blood platelets

Thrombosis Research

Volumn 109, Issue 5-6, 2003, Pages 307-314

  Maekawa, Yuichi ^a   Yagi, Kyouko ^a   Nonomura, Ayako ^a   Kuraoku, Rie ^a   Nishiura, Emi ^a   Uchibori, Emi ^a   Takeuchi, Kikuko ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Platelet aggregation; Platelet cryopreservation; Platelet in vitro viability; WST 8 assay

Indexed keywords

4 [3 (2 METHOXY 4 NITROPHENYL) 2 (4 NITROPHENYL) 2H 5 TETRAZOLIO] 1,3 BENZENE DISULFONATE SODIUM; BANBANKER; CRYOPROTECTIVE AGENT; DODECYL SULFATE SODIUM; FORMAZAN; IODOACETIC ACID; TETRAZOLIUM; UNCLASSIFIED DRUG; WATER;

ADULT; AGGREGOMETER; ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL ASSAY; CELL COUNT; CELL DEATH; COLORIMETRY; DEVICE; FREEZING; GLYCOLYSIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORMAL HUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SPECTROPHOTOMETER; TEMPERATURE; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE METABOLISM;

EID: 0038344832     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00257-3     Document Type: Article

References (38)

1. Rock G., Swenson S.D., Adams G.A. Platelet storage in a plasma free medium. Transfusion. 25:1985;551-556.
2. Holme S., Heaton W.A., Courtright M. Improved in vivo and in vitro viability of platelet concentrates stored for seven days in a platelet additive solution. Br. J. Haematol. 66:1987;233-238.
3. Murphy S., Shimizu T., Miripol J. Platelet storage for transfusion in synthetic media: further optimization of ingredients and definition of their roles. Blood. 86:1995;3951-3960.
4. Connor J., Currie L.M., Allan H., Livesey S.A. Recovery of in vitro functional activity of platelet concentrates stored at 4°C and treated with second-messenger effectors. Transfusion. 36:1996;691-698.
5. Murphy S., Kahn R.A., Holme S., Phillips G.L., Sherwood W., Davisson Wa. et al. Improved storage of platelets for transfusion in a new container. Blood. 60:1982;194-200.
6. Schiffer C.A., Lee E.J., Ness P.M., Reilly J. Clinical evaluation of platelet concentrates stored for one to five day. Blood. 67:1986;1591-1594.
7. Racz Z., Hasko F. Room temperature storage of pooled platelet concentrates in gas permeable plastic bags for five days. Haematologia. 22:1989;89-96.
8. Valeri C.R., Feingold H., Marchionni L.D. A simple method for freezing human platelets using 6% dimethylsulfoxide and storage at -80°C. Blood. 43:1974;131-136.
9. Schiffer C.A., Buchholz D.H., Aisner J., Wolff J.H., Wierinik P.H. Frozen autologous platelets in the supportive care of patients with leukemia. Transfusion. 16:1976;321-329.
10. Spector J.I., Yarmala J.A., Marchionni L.D., Emerson C.P., Valeri C.R. Viability and function of platlets frozen at 2 to 3°C per minute with 4 or 5 per cent DMSO and stored at -80°C for 8 months. Transfusion. 17:1977;8-15.
11. Schiffer C.A., Aisner J., Wiernik P.H. Frozen autologous platelet transfusion for patients with leukemia. N. Engl. J. Med. 299:1978;7-12.
12. Owens M., Cimino C., Donnelly J. Cryopreserved platelets have decreased adhesive capacity. Transfusion. 31:1991;160-163.
13. Bock M., Schleuning M., Heim M.U., Mempel W. Cryopreservation of human platelets with dimethyl sulfoxide: changes in biochemistry and cell function. Transfusion. 35:1995;921-924.
14. Currie L.M., Livesey S.A., Harper J.R., Connor J. Cryopreservation of single-donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second-messenger effectors: enhanced retention of in vitro functional activity. Transfusion. 38:1998;160-167.
15. Arnaud F. Frozen/thawed platelets: importance of osmotic tolerance and platelet subpopulations. Cryobiology. 38:1999;192-199.
16. Xiao H., Harvey K., Labarrere C.A., Kovacs R. Platelet cryopreservation using a combination of epinephrine and dimethyl sulfoxide as cryoprotectants. Cryobiology. 41:2000;97-105.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
18. Hardeman M.R., Heynens C.J. Storage of human blood platelets. the serotonin uptake and hypotonic shock response as in vitro viability tests. Thromb. Diath. Haemorrh. 32:1974;405-416.
19. Odink J., Brank A. Platelet preservation V. survival, serotonin uptake velocity, and response to hypotonic stress of fresh and cryopreserved human platelets. Transfusion. 17:1977;203-209.
20. Alley M.C., Scudiero D.A., Monks A., Hursery M.L., Czerwinski M.J., Fine D.L.et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48:1988;589-601.
21. Weislow O.S., Kiser R., Fine D.L., Bader J., Shoemaker R.H., Boyd M.R. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J. Natl. Cancer Inst. 81:1989;577-586.
22. Tan A.S., Berridge M.V. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: a simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J. Immunol. Methods. 238:2000;59-68.
23. Marshall N.J., Goodwin C.J., Holt S.J. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul. 5:1995;69-84.
24. Ishiyama M., Miyazono Y., Sasamoto K., Ohkura Y., Ueno K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 44:1997;1299-1305.
25. Vanhee D., Joseph M., Vorng H., Tonnel A.B. A colorimetric assay to evaluate the immune reactivity of blood platelets based on the reduction of a tetrazolium salt. J. Immunol. Methods. 159:1993;253-259.
26. Arnaud F.G., Hunt C.J., Pegg D.E. Some effects of propane-1,2-diol on human platelets. Cryobiology. 27:1990;119-129.
27. Vaga M.V., Maheswaran S.K., Leininger J.R., Ames T.R. Adaptation of colorimetric microtitration assay for quantifying Pasteurella haemolytica A1 leukotoxin and antileukotoxin. Am. J. Vet. Res. 48:1987;1559-1564.
28. Wallvik J., Suontaka A.M. Limited metabolic effect of mononuclear cells in platelet storage. Thromb. Res. 70:1993;255-264.
29. Basha G., Yap P., Penninckx F. Comparative study of classical, colorimetric and immunologic staining methods for the assessment of tumor cell viability. Tumour Biol. 17:1996;354-361.
30. Matsuoka M., Wispriyono B., Igisu H. Increased cytotoxicity of cadmium in fibroblasts lacking c-fos. Biochem. Pharmacol. 59:2000;1573-1576.
31. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): sobcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303:1993;474-482.
32. Kilkson H., Holme S., Murphy S. Platelet metabolism during storage of platelet concentrates at 22°C. Blood. 64:1984;406-414.
33. Dunigan D.D., Waters S.B., Owen T.C. Aqueous soluble tetrazolium/formazan MTS as an indicator of NADH- and NADPH-dependent dehydrogenase activity. BioTechniques. 19:1995;640-649.
34. Chanock S.J., Benna J., Smith R.M., Babior B.M. The respiratory burst oxidase. J. Biol. Chem. 269:1994;24519-24522.
35. Holmsen H., Robkin L., Day H.J. Effects of antimycin A and 2-deoxy-glucose on secretion in human platelets. Differential inhibition of the secretion of acid hydrolases and adenine nucleotides. Biochem. J. 182:1979;413-419.
36. Guppy M., Abas L., Arthur P.G., Whisson M.E. The Pasteur effect in human platelets: implications for storage and metabolic control. Br. J. Haematol. 91:1995;752-757.
37. Lozano M.L., Rivera J., Gonzalez-Conejero R., Moraleda J.M., Vicente V. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin. Transfusion. 37:1997;368-375.
38. Owens M., Werner E., Holme S., Afflerbach C. Membrane glycoproteins in cryopreserved platelets. Vox Sang. 67:1994;28-31.